{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:07:17Z","timestamp":1790165237745,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.rpth.2026.106799","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T01:12:12Z","timestamp":1781313132000},"page":"106799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A review of the pharmacokinetics, pharmacodynamics, efficacy, and safety of direct oral anticoagulants in patients undergoing bariatric surgery"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8736-6619","authenticated-orcid":false,"given":"Dino","family":"Kr\u00f6ll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Stirnimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereck","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106799_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.15386\/mpr-1372","article-title":"Association between obesity and venous thromboembolism","volume":"93","author":"Hotoleanu","year":"2020","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.rpth.2026.106799_bib3","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.amjmed.2021.07.017","article-title":"Oral anticoagulant use in morbid obesity and post bariatric surgery: a review","volume":"134","author":"Nasser","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2026.106799_bib4","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1161\/CIRCRESAHA.116.307591","article-title":"Treatment of obesity: weight loss and bariatric surgery","volume":"118","author":"Wolfe","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.rpth.2026.106799_bib6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s11695-024-07118-3","article-title":"IFSO worldwide survey 2020-2021: current trends for bariatric and metabolic procedures","volume":"34","author":"Angrisani","year":"2024","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib7","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s11695-024-07196-3","article-title":"Metabolic bariatric surgery across the IFSO chapters: key insights on the baseline patient demographics, procedure types, and mortality from the eighth IFSO global registry report","volume":"34","author":"Brown","year":"2024","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib8","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1007\/s11695-013-1073-1","article-title":"Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study","volume":"23","author":"Froehling","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.soard.2021.10.023","article-title":"The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery","volume":"18","author":"Aminian","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.rpth.2026.106799_bib10","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.15358","article-title":"Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Martin","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106799_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.thromres.2017.11.006","article-title":"The effect of bariatric surgery on direct-acting oral anticoagulant drug levels","volume":"163","author":"Rottenstreich","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106799_bib12","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jth.15823","article-title":"Direct oral anticoagulants after bariatric surgery-what is the evidence?","volume":"20","author":"Leong","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106799_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjmed.2016.12.033","article-title":"Oral anticoagulant use after bariatric surgery: a literature review and clinical guidance","volume":"130","author":"Martin","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2026.106799_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rpth.2026.106799_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s40262-015-0342-7","article-title":"Pharmacokinetics and pharmacodynamics of edoxaban, a non-vitamin K antagonist oral anticoagulant that inhibits clotting factor Xa","volume":"55","author":"Parasrampuria","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rpth.2026.106799_bib16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s40262-019-00775-z","article-title":"Apixaban: a clinical pharmacokinetic and pharmacodynamic review","volume":"58","author":"Byon","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rpth.2026.106799_bib17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.soard.2025.05.004","article-title":"Efficacy and safety of direct oral anticoagulants (DOACs) for postoperative thromboprophylaxis in patients after bariatric surgery: a systematic review and meta-analysis","volume":"21","author":"Bicudo Bregion","year":"2025","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.rpth.2026.106799_bib18","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/bcp.13243","article-title":"Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery","volume":"83","author":"Kr\u00f6ll","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rpth.2026.106799_bib19","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.soard.2018.08.025","article-title":"The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study","volume":"14","author":"Kr\u00f6ll","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.rpth.2026.106799_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.15241","article-title":"Efficacy and safety of rivaroxaban for postoperative thromboprophylaxis in patients after bariatric surgery: a randomized clinical trial","volume":"6","author":"Kr\u00f6ll","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rpth.2026.106799_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.soard.2021.12.023","article-title":"The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypass","volume":"18","author":"Steele","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.rpth.2026.106799_bib22","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s11695-025-07721-y","article-title":"Comparison between low molecular weight heparin and apixaban (direct oral anticoagulant) in the prophylaxis against venous thromboembolism after laparoscopic sleeve gastrectomy","volume":"35","author":"Abdelsalam","year":"2025","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib23","author":"Myung"},{"key":"10.1016\/j.rpth.2026.106799_bib24","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106799_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/01.3001.0016.2729","article-title":"Prolonged thromboprophylaxis with rivaroxaban after bariatric interventions: single centre experience","volume":"95","author":"Tyselskyi","year":"2023","journal-title":"Pol Przegl Chir"},{"key":"10.1016\/j.rpth.2026.106799_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1308\/rcsann.2020.0209","article-title":"Prophylaxis with rivaroxaban after laparoscopic sleeve gastrectomy could reduce the frequency of portomesenteric venous thrombosis","volume":"102","author":"Rodr\u00edguez","year":"2020","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.rpth.2026.106799_bib27","article-title":"The influence of enoxaparin or rivaroxaban for venous thromboembolism in morbidly obese patients undergoing bariatric surgery","volume":"5","author":"Bayat","year":"2022","journal-title":"Med Clin Pract"},{"key":"10.1016\/j.rpth.2026.106799_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s11695-023-06471-z","article-title":"30-day post-discharge prophylaxis with rivaroxaban prevents porto-mesenteric venous thrombosis following laparoscopic sleeve gastrectomy","volume":"33","author":"Swartz","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib29","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11695-024-07100-z","article-title":"Extended post discharge prophylaxis for venous thromboembolism prevention after bariatric surgery","volume":"34","author":"Guzman-Pruneda","year":"2024","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11695-022-06051-7","article-title":"The safety and efficacy of apixaban (Eliquis) in 5017 post-bariatric patients with 95.3% follow-up: a multicenter study","volume":"32","author":"Surve","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib31","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1007\/s11695-025-08036-8","article-title":"Impact of prophylactic apixaban for 14 days after sleeve gastrectomy on thromboembolic events and its side effects","volume":"35","author":"Galvao Goncalves","year":"2025","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib32","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1016\/j.jtha.2025.08.005","article-title":"Absorption of apixaban following metabolic and bariatric surgery: is reluctance still warranted?","volume":"23","author":"Berends","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106799_bib33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s11695-025-08419-x","article-title":"Effects of bariatric surgery on the pharmacokinetics of cardiovascular drugs: a systematic review and meta-analysis","volume":"36","author":"Zarinfar","year":"2026","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11239-013-1029-2","article-title":"A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban","volume":"38","author":"Kreutz","year":"2014","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2026.106799_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11695-013-1105-x","article-title":"Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study)","volume":"24","author":"Imberti","year":"2014","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1381\/09608920160558588","article-title":"Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial","volume":"11","author":"Kalfarentzos","year":"2001","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1553350620965812","article-title":"Incidence of silent deep venous thrombosis after laparoscopic bariatric surgery in patients who received combined mechanical and chemical thromboprophylaxis compared to patients who received mechanical thromboprophylaxis only","volume":"28","author":"Ahmad","year":"2021","journal-title":"Surg Innov"},{"key":"10.1016\/j.rpth.2026.106799_bib38","series-title":"Prescribing information. Titusville, NJ: Janssen Pharmaceuticals","year":"2026"},{"key":"10.1016\/j.rpth.2026.106799_bib39","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/jth.13323","article-title":"Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH","volume":"14","author":"Martin","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106799_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/0091270006296058","article-title":"Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects","volume":"47","author":"Kubitza","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.rpth.2026.106799_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.thromres.2016.09.010","article-title":"Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience","volume":"147","author":"Arachchillage","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106799_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/psp4.12288","article-title":"Integrated population pharmacokinetic analysis of rivaroxaban across multiple patient populations","volume":"7","author":"Willmann","year":"2018","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.rpth.2026.106799_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11695-021-05814-y","article-title":"Anti-Xa levels in morbidly obese patients using apixaban or rivaroxaban, before and after bariatric surgery","volume":"32","author":"Kok","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106799_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.thromres.2018.02.006","article-title":"Reply to: the effect of bariatric surgery on direct-acting oral anticoagulant drug levels","volume":"164","author":"Kr\u00f6ll","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106799_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cpdd.123","article-title":"Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube","volume":"3","author":"Moore","year":"2014","journal-title":"Clin Pharmacol Drug Dev"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:53:41Z","timestamp":1790164421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926034576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2475037926034576"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106799","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the pharmacokinetics, pharmacodynamics, efficacy, and safety of direct oral anticoagulants in patients undergoing bariatric surgery","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106799"}}